(142 days)
Kontact™ Dental Implant System is indicated for use in partially or fully edentulous patients to support maxillary or mandibular single unit, multiple-unit, or overdenture dental restorations. Kontact Dental Implant System is indicated for immediate loading when good primary stability is achieved and the occlusal loading is appropriate. Kontact 3 mm diameter implants and prosthetics components are indicated for use in surgical and restorative applications in the maxillary lateral incisor or mandibular incisor regions.
The Kontact™ Dental Implant System comprises endosseous root-form dental implants, abutments, abutment screws, and other associated components for single-unit, multi-unit, and overdenture restorations. Kontact dental implants are provided in five body diameters: 3.0 mm, 3.6 mm, 4.2 mm, 4.8 mm, and 5.4 mm. The platform diameter for each size is the same as the (maximum) body diameter. The implants are provided in lengths ranging from 8 mm to 16 mm. The implants have a recessed internal section for abutment indexing, and an internal threaded section for mating to the corresponding subject device cover screw, or abutment screw. All implants are manufactured from titanium alloy conforming to ASTM F136 and ISO 5832-3. The endosseous threaded surface of the subject device implants is grit-blasted with non-resorbable aluminum oxide (Al2O3) particles. Kontact conventional and prosthetic components include cover screws, abutment screws, temporary abutments, straight abutments, angled abutments, prepable abutments, multi-unit abutments, healing caps, and overdenture abutments. Most device screws and all subject device abutments are manufactured from titanium alloy conforming to ASTM F136 and ISO 5832-3. Select subject device abutments and screws manufactured from titanium alloy are anodized using standard electrolytic passivation processing to impart a distinctive surface color. The subject device abutment screw intended for 3 mm diameter implants and the prosthesis screw intended for conical abutments are manufactured from cobalt alloy, conforming to ASTM F1058 and ISO 5832-7. The abutment screw is coated with titanium nitride (TiN); the prosthesis screw is coated with chromium nitride (CrN). Subject device healing caps intended for use with UniPost abutments, and IsoPost abutments are manufactured from polyetheretherketone (PEEK). Subject device healing caps intended for NanoPost abutments and IsoPost abutments are manufactured from polymethyl methacrylate (PMMA).
The product, Kontact™ Dental Implant System, has not reported any clinical studies. The only data provided is non-clinical performance data.
Here's the breakdown of the information requested, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
| Test/Evaluation Type | Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|---|
| Biocompatibility | Conformance to ISO 10993-5 and ISO 10993-12 | Device demonstrates biocompatibility according to ISO 10993-5 (tests for in vitro cytotoxicity) and ISO 10993-12 (sample preparation and reference materials). Specific results are not detailed but compliance with these standards indicates meeting requirements for biological safety. |
| Gamma Sterilization | Conformance to ISO 11137-1 and ISO 11137-2 | Validation performed for subject device implants and cover screws. Specific Sterility Assurance Levels (SAL) are not stated, but conformance to these standards implies achieving a validated sterile state (e.g., SAL of 10^-6). |
| Bacterial Endotoxin Testing (BET) | ≤ 20 EU/device | Limulus amebocyte lysate (LAL) test performed according to ANSI/AAMI ST72 and USP 43-NF38:2020 <85>. Ongoing monitoring and control ensure BET levels meet or are below ≤ 20 EU/device. This indicates the devices are free from pyrogenic contamination within accepted limits. |
| Shelf Life Validation | Conformance to ASTM F1980 and ISO 11607-1 | Packaging stability validated. Conformance to ASTM F1980 (standard guide for accelerated aging of sterile medical device packages) and ISO 11607-1 (packaging for terminally sterilized medical devices) indicates the device maintains its integrity and sterility over its claimed shelf life. Specific shelf life duration is not provided. |
| Moist Heat Sterilization (End-user) | Conformance to ISO 17665-1 and ISO TS 17665-2 | Instructions and validation for end-user moist heat sterilization provided. Conformance to ISO 17665-1 (sterilization of health care products - moist heat - requirements for the development, validation and routine control of a sterilization process for medical devices) and ISO TS 17665-2 (guidance on the application of ISO 17665-1) ensures proper sterilization by the end-user. Specific parameters are not detailed. |
| Static Compression & Compression Fatigue Testing | Conformance to ISO 14801 | Mechanical performance testing performed on the subject device according to ISO 14801 (dentistry - implants - dynamic fatigue test for endosseous dental implants). The fatigue limit data for abutments compatible with 3.0 mm diameter implants was supported by reference device K183518, and "constructs of all other subject device abutments in combination with all other subject device implants have sufficient strength for their intended use." This indicates the devices meet mechanical strength requirements for their intended application. The specific criteria for "sufficient strength" are not explicitly quantified (e.g., number of cycles survived, load at failure) but implied by conformance to the standard. |
| Endosseous Surface Characterization | Demonstrated by SEM and EDS | The grit-blasted surface (with non-resorbable aluminum oxide) was validated by scanning electron microscope (SEM) and energy dispersive X-ray spectroscopy (EDS) characterization. This confirms the presence and composition of the surface modification intended to facilitate osseointegration. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not explicitly stated for any of the non-clinical tests.
- Data Provenance: All data is non-clinical and derived from laboratory testing of the device and its components, primarily referencing international and industry standards (ISO, ASTM, ANSI/AAMI, USP). Information on the country of origin of the test data is not provided, but the manufacturer is Biotech Dental, SAS, based in France. The data is retrospective in the sense that it's generated as part of a premarket submission, not from a prospective clinical trial.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- Not applicable. This device relies on pre-defined engineering and sterility standards, not expert-established ground truth from clinical cases. There were no clinical studies.
4. Adjudication Method (e.g., 2+1, 3+1, none) for the Test Set
- Not applicable. There was no test set for clinical performance requiring adjudication.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance
- Not applicable. No clinical studies were conducted, and this product does not involve AI or human reader interpretation.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
- Not applicable. This product is a physical dental implant system, not a software algorithm.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc)
- Not applicable. Ground truth, in the clinical sense, was not used as there were no clinical studies. The "ground truth" for non-clinical testing is adherence to established international and industrial standards (e.g., ISO, ASTM) for material properties, mechanical performance, and sterility.
8. The Sample Size for the Training Set
- Not applicable. There was no training set, as this is a physical medical device and not an AI/ML algorithm.
9. How the Ground Truth for the Training Set Was Established
- Not applicable. There was no training set.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Biotech Dental, SAS % Kevin Thomas Vice President and Director of Regulatory Affairs PaxMed International. LLC 12264 El Camino Real, Suite 400 San Diego, California 92130
Re: K210220
Trade/Device Name: Kontact™ Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: May 17, 2021 Received: May 18, 2021
Dear Kevin Thomas:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Andrew I. Steen Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
Device Name Kontact™ Dental Implant System
Indications for Use (Describe)
Kontact™ Dental Implant System is indicated for use in partially or fully edentulous patients to support maxillary or mandibular single unit, multiple-unit, or overdenture dental restorations. Kontact Dental Implant System is indicated for immediate loading when good primary stability is achieved and the occlusal loading is appropriate. Kontact 3 mm diameter implants and prosthetics components are indicated for use in surgical and restorative applications in the maxillary lateral incisor or mandibular incisor regions.
Type of Use (Select one or both, as applicable)
| X Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| □ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) Summary K210220 Kontact™ Dental Implant System Biotech Dental, SAS
June 17, 2021
ADMINISTRATIVE INFORMATION
| Manufacturer Name | Biotech Dental, SAS | |
|---|---|---|
| 305, Allées de Craponne | ||
| 13300 Salon de Provence | ||
| France | ||
| Telephone: | +33 (0) 4 90 44 60 60 | |
| Fax: | +33 (0) 4 90 44 60 61 | |
| Official Contact | Delphine Mercier, Vice President, Compliance | |
| Representative/Consultant | Kevin A. Thomas, PhD | |
| Floyd G. Larson, MS, MBA | ||
| PaxMed International, LLC | ||
| 12264 El Camino Real, Suite 400 | ||
| San Diego, CA 92130 | ||
| Telephone: | +1 858-792-1235 | |
| Fax: | +1 858-792-1236 | |
| Email: | kthomas@paxmed.com | |
| flarson@paxmed.com |
DEVICE NAME AND CLASSIFICATION
| Trade/Device Name | Kontact™ Dental Implant System |
|---|---|
| Common Name | Implant, Endosseous, Root-Form |
| Abutment, Implant, Dental, Endosseous | |
| Regulation Number | 21 CFR 872.3640 |
| Regulation Name | Endosseous dental implant |
| Regulatory Class | Class II |
| Product Code | DZE |
| Secondary Product Code | NHA |
| Classification Panel: | Dental |
| Reviewing Office | Office of Health Technology 1 (Ophthalmic, Anesthesia, Respiratory, |
| ENT and Dental Devices) | |
| Reviewing Division | Division of Health Technology 1 B (Dental Devices) |
{4}------------------------------------------------
PREDICATE DEVICE INFORMATION
Primary Predicate Device K120414, OsseoSpeedTM Plus, Astra Tech AB
Reference Devices
K123988, AnyOne™ Internal Implant System, MegaGen Implant Co., Ltd K131644, Ankylos SynCone® Abutment 5°, Dentsply International, Incorporated K 153509, GPS® Angled Abutments, Implant Direct Sybron Manufacturing, LLC K163194. Neodent Implant System - GM Line. JJGC Industria e Comercio de Materiais Dentarios SA K 170392, S.I.N. Dental Implant System, S.I.N. - Sistema de Implante Nacional S.A. K182448, AnyRidge Octa 1 Implant System, MegaGen Implant Co., Ltd K192347, ST Internal Implant System, MegaGen Implant Co., Ltd K200992, S.I.N. Dental Implant System, S.I.N. - Sistema de Implante Nacional S.A. K151328, PURE Ceramic Implants, Straumann, USA K181381, A.B. Dental Devices® Dental Implants System, A.B. Dental Device Ltd. K183518, Preat Abutments, Preat Corporation K200386, Z5-BL, Z-Systems AG K152787, ST Internal Fixture System, T-Plus Implant Tech. Co., Ltd. K092341, Low Profile Abutment, Biomet 3i, Inc. K203355, Straumann TLX Novaloc and Cementable Abutments, Institut Straumann AG
INDICATIONS FOR USE STATEMENT
Kontact™ Dental Implant System is indicated for use in partially or fully edentulous patients to support maxillary or mandibular single unit, multiple-unit, or overdenture dental restorations. Kontact Dental Implant System is indicated for immediate loading when good primary stability is achieved and the occlusal loading is appropriate. Kontact 3 mm diameter implants and prosthetics components are indicated for use in surgical and restorative applications in the maxillary lateral incisor or mandibular incisor regions.
SUBJECT DEVICE DESCRIPTION
The purpose of this submission is to obtain marketing clearance for Kontact™ Dental Implant System which comprises endosseous root-form dental implants, abutments, abutment screws, and other associated components for single-unit, multi-unit, and overdenture restorations.
Kontact dental implants are provided in five body diameters: 3.0 mm, 4.2 mm, 4.8 mm, and 5.4 mm. The platform diameter for each size is the same as the (maximum) body diameter. The implants are provided in lengths ranging from 8 mm to 16 mm. The subject device dental implants are summarized on the following page.
The implants have a recessed internal section for abutment indexing, and an internal threaded section for mating to the corresponding subject device cover screw, or abutment screw. All implants are manufactured from titanium alloy conforming to ASTM F136 and ISO 5832-3. The endosseous threaded surface of the subject device implants is grit-blasted with non-resorbable aluminum oxide (Al2O3) particles. This rough surface provides an increase in total contact area of the implant surface to facilitate osseointegration.
{5}------------------------------------------------
| Body Diameter (mm) | Lengths (mm) | |
|---|---|---|
| Kontact Dental Implants | 3.0 | 10, 12, 14 |
| 3.6 | 8, 10, 12, 14, 16 | |
| 4.2 | 8, 10, 12, 14, 16 | |
| 4.8 | 8, 10, 12, 14 | |
| 5.4 | 8, 10, 12, 14 |
Kontact™ Dental Implant Sizes
Kontact conventional and prosthetic components include cover screws, abutment screws, temporary abutments, straight abutments, angled abutments, prepable abutments, multi-unit abutments, healing caps, and overdenture abutments. The Kontact abutment and prosthetic components are summarized in the following table.
| Coronal Ø, mm | Angle, ° | Material | |
|---|---|---|---|
| Cover Screws | 2.5 - 2.9 | n/a | Titanium Alloy |
| Healing Screws | 4.1 - 7.1 | n/a | Titanium Alloy |
| Abutment Screws | 2.0 | n/a | Titanium Alloy,Cobalt Alloy |
| Prosthetic Platform Ø, mm | |||
| Temporary Abutments | 4.0 - 4.5 | n/a | Titanium Alloy |
| Non-Scalloped Straight Abutments | 3.7 - 6.5 | n/a | Titanium Alloy |
| Scalloped Straight Abutments | 3.8 - 6.6 | n/a | Titanium Alloy |
| Non-Scalloped Angled Abutments | 3.7 - 6.5 | 7.5, 15, 22 | Titanium Alloy |
| Scalloped Angled Abutments | 3.8 - 6.6 | 7.5, 15, 22 | Titanium Alloy |
| FitPost Abutment | 5.1 - 6.6 | n/a | Titanium Alloy |
| NanoPost Straight Abutments | 4.3 - 5.5 | n/a | Titanium Alloy |
| NanoPost Angled Abutments | 4.3 | 7.5, 15 | Titanium Alloy |
| NanoPost Healing Caps | 4.3 - 5.5 | n/a | PMMA |
| UniPost Abutments | 4.0 - 6.5 | n/a | Titanium Alloy |
| UniPost Healing Caps | 4.0 - 6.5 | n/a | PEEK |
| Straight Conical Abutments | 4.0 - 4.9 | n/a | Titanium Alloy |
| Angled Conical Abutments | 4.0 - 4.9 | 17 | Titanium Alloy |
| Conical Healing Caps | 4.0 - 4.9 | n/a | PEEK |
| IsoPost Straight Abutments | 4.1 | n/a | Titanium Alloy |
| IsoPost Angled Abutments | 4.1 | 7.5, 15, 22 | Titanium Alloy |
| IsoPost Healing Caps | 4.9 -5.3 | n/a | PEEK, PMMA |
| Ball Abutments | n/a | n/a | Titanium Alloy |
Kontact™ Screws, Abutments, and Healing Caps
{6}------------------------------------------------
Most device screws and all subject device abutments are manufactured from titanium alloy conforming to ASTM F136 and ISO 5832-3. Select subject device abutments and screws manufactured from ttannum alloy are anodized using standard electrolytic passivation processing to impart a distinctive surface color. No dyes or color additives are used to impart color on the subject devices. All subject device screws and abutments corresponding to the subject device 3 mm diameter implants are anodized yellow. All other color-coded subject device components are anodized magenta, orange, green, blue, or brown.
The subject device abutment screw intended for 3 mm diameter implants and the prosthesis screw intended for conical abutments are manufactured from cobalt alloy, conforming to ASTM F1058 and ISO 5832-7. The abutment screw is coated with titanium nitride (TiN); the prosthesis screw is coated with chromium nitride (CrN). The coatings are created in a physical vapor deposition (PVD) process.
Subject device healing caps intended for use with UniPost abutments, and IsoPost abutments are manufactured from polyetheretherketone (PEEK). Subject device healing caps intended for NanoPost abutments and IsoPost abutments are manufactured from polymethyl methacrylate (PMMA).
PERFORMANCE DATA
The subject device was evaluated and tested as recommended in the FDA guidance documents Root Form Endosseous Dental Implants and Endosseous Dental Implant Abutments (issued May 12, 2004), Use of International Standard ISO 10993-1, "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process" (issued September 4, 2020), Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling (issued March 17, 2015), Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile (issued January 21, 2016), and Pyrogen and Endotoxins Testing: Ouestions and Answer (issued June 2012).
Non-clinical data submitted to demonstrate substantial equivalence included: gamma sterilization validation for subject device implants and cover screws according to ISO 11137-1 and ISO 11137-2: bacterial endotoxin (BET) testing including Limulus amebocyte lysate (LAL) test according to ANSI/AAMI ST72 and USP 43-NF38:2020 <85>; shelf life validation through packaging stability per ASTM F1980 and in conformance with ISO 11607-1; moist heat sterilization (to be performed by the end-user) according to ISO 17665-1 and ISO TS 17665-2; biocompatibility according to ISO 10993-5 and ISO 10993-12; and static compression and compression fatigue testing according to ISO 14801.
The endosseous threaded surface of the subject device implants is grit-blasted with non-resorbable aluminum oxide (Al2O3) particles; this surface was validated by scanning electron microscope (SEM) and energy dispersive X-ray spectroscopy (EDS) characterization.
Bacterial endotoxins in the subject devices provided sterile to the end user will be monitored and controlled by measuring BET levels using a monthly sampling plan to ensure that the BET level meets the level of ≤ 20 EU/ device.
No clinical data were included in this submission.
{7}------------------------------------------------
EQUIVALENCE TO MARKETED DEVICES
The subject devices are substantially equivalent in indications and design principles to the primary predicate device and reference devices listed above. Provided at the end of this summary is a table comparing the Indications for Use Statements and tables comparing the technological characteristics of the subject device, the primary predicate device, and the reference devices.
The Indications for Use Statement (IFUS) for the subject device is substantially equivalent to that of the primary predicate device K120414 and the reference devices. Slight differences in the language of the IFUS do not affect the intended use as an endosseous dental implant and dental implant abutments for support of a prosthesis to restore chewing function.
Minor differences between the IFUS for the subject device and the primary predicate device K120414 are listed below. These minor differences do not raise new questions of safety or effectiveness because the IFUS express equivalent intended use.
The predicate device IFUS states that the "The Astra Tech Dental Implants are intended for ... immediate loading in all indications, except single tooth situations on implants shorter than 8 mm, or in soft bone (type IV) where implant stability may be difficult to obtain and immediate loading may be appropriate." The subject device IFUS does not provide an exception for implant lengths shorter than 8 mm because the subject device implants range from 8 mm to 16 mm. Therefore, the exception is not applicable. The subject device IFUS states that "Kontact Dental Implant System is indicated for immediate loading when good primary stability is achieved and occlusal loading is appropriate." This statement is inclusive of soft bone (type IV).
Similarly, the subject device IFUS states more concisely, the primary predicate IFUS that " ... Implants are intended for both one- and two-stage surgical procedures in the following situations and with the following clinical protocols: • replacing single and multiple missing teeth in the mandible and maxilla . immediate placement in extraction sites and in situations with a partially or completely healed alveolar ridge • especially indicated for use in soft bone applications where implants with other implant surface treatments may be less effective" with the sentence "Kontact Dental Implant System is indicated for use in partially or fully edentulous patients to support maxillary or mandibular single unit, multiple-unit, or overdenture dental restorations."
The predicate device IFUS states that "The intended use for OsseoSpeed™ Plus 3.0S is limited to replacement of maxillary lateral incisors and mandibular incisors." The subject device IFUS states that "Kontact 3 mm diameter implants and prosthetics components are indicated for use in surgical and restorative applications in the maxillary lateral incisor or mandibular incisor regions." The specification of "implants and prosthetic components" and "in surgical restorative applications" in the subject device IFUS is the same intended use compared to the more generic suggestion in the predicate device IFUS.
The predicate IFUS for the Atlantis Abutments is the same intended use as the subject device IFUS for the Kontact Dental Implant System includes both the subject device implants and the subject device prosthetic components.
The subject device does not include any patient-specific abutments or crowns fabricated using CAD-CAM technology; therefore, the subject device IFUS does not have an equivalent statement to the Atlantis™ Crown Abutment.
Minor differences between the IFUS for the subject device and the reference devices K123988, K182448, and K192347 are listed below. These minor differences do not raise new questions of safety or effectiveness because IFUS express equivalent intended use.
{8}------------------------------------------------
The reference device IFUS includes the terms "Crown, bridges, and overdentures" and the subject device IFUS uses alternative terminology "single-unit, multiple-unit, and overdenture dental restorations".
The reference device IFUS states "Smaller implants (less than Ø 6.0 mm) are dedicated for immediate loading when good primary stability is achieved and with appropriate occlusal loading. Larger implants are dedicated for the molar region and are indicated for delayed loading". The subject device IFUS does not define implants with a diameter less than 6.0 mm as "smaller" or implants with a diameter 6.0 mm or greater as "larger" because the subject device implants are not provided in diameters greater than 5.4 mm. Therefore, the sentence "Kontact Dental Implant System is indicated for immediate loading when good primary stability is achieved and the occlusal loading is appropriate" in the subject device IFUS is equivalent to the reference device's "smaller implants" and a restriction on "larger" implants is not applicable
Conversely, the subject device IFUS includes a restriction on 3.0 mm diameter implants and the compatible prosthetic components to the maxillary lateral incisor and mandibular incisor regions. The reference device IFUS does not include the restriction because the smallest diameter reference device is 4.0 mm.
The reference device IFUS and the subject device IFUS include different tradenames.
Minor differences between the IFUS for the subject device and the reference device K131644 are listed below. These minor differences do not raise new questions of safety or effectiveness because the IFUS express equivalent intended use.
The reference device IFUS includes reference to edentulous mandible supported by 4 ANKYLOS® implants of at least 11 mm in length and placed interforaminally which is not applicable to the subject device IsoPost abutments.
The reference device IFUS and the subject device IFUS include different tradenames.
Minor differences between the IFUS for the subject device and the reference device K153509 are listed below. These minor differences do not raise new questions of safety or effectiveness because both IFUS express equivalent intended use.
The reference device IFUS and the subject device IFUS include different tradenames.
The reference device IFUS is limited to abutments for multi-unit bridge or overdenture that are compatible with original equipment manufacturer (OEM) implant systems. The subject device IFUS does not include compatible OEM implant systems because the subject devices and accessories are not compatible with any previously cleared dental implants or prosthetic components. Additionally, the subject device IFUS specifies the Kontact Dental Implant System, which encompasses implants, abutments, and accessories.
Minor differences between the IFUS for the subject device and the reference device K163194 are listed below. These minor differences do not raise new questions of safety or effectiveness because both IFUS express equivalent intended use.
The reference device IFUS includes indications for titanium base abutments and PEEK abutments. The subject device IFUS does not include these indications because the subject device product list does not include components that are indicated for use with CAD-CAM technology or abutments manufactured from PEEK. Subject device components manufactured from PEEK are limited to healing caps.
The reference device IFUS and the subject device IFUS include different tradenames.
{9}------------------------------------------------
Minor differences between the IFUS for the subject device and the reference device K170392 are listed below. These minor differences do not raise new questions of safety or effectiveness because both IFUS express equivalent intended use.
The reference device IFUS specifies that "Implants with lengths less than 7 mm are intended for delayed loading only." The subiect device IFUS does not restrict implant lengths less than 7 mm for delayed loading only because the subject device implants range from 8 mm to 16 mm. Therefore, the restriction is not applicable.
The reference device IFUS and the subject device IFUS include different tradenames.
Minor differences between the IFUS for the subject device and the reference device K183518 are listed below. These minor differences do not raise new questions of safety or effectiveness because both IFUS express equivalent intended use.
The reference device IFUS and the subject device IFUS include different tradenames.
The reference device IFUS includes indications for titanium blanks and titanium base abutment, refences to validated milling centers, and compatible OEM implant systems. The subject device IFUS does not include these elements because the subject device does not include components that are indicated for use with CAD-CAM technology to fabricate patient-specific abutments prescribed by the clinician. Furthermore, the subject device and accessories are not compatible with any previously cleared dental implants or prosthetic components.
Minor differences between the IFUS for the subject device and the reference devices K152787, K092341, and K203355 include: only K152787 includes language regarding implants, and does not include any limitations for small diameter implants; K152787 and K092341 do not mention specific types of restorations (single-unit, multi-unit, or overdentures); and K203355 mentions only dentures. These minor differences do not raise new questions of safety or effectiveness because both IFUS express equivalent intended use.
Last, the differences in IFUS for K151328, K181381, and K200386 are not applicable for the assessment of substantial equivalence in terms of intended use because these are reference devices for materials and modified surface information.
Subject Device Dental Implants
The subject device Kontact dental implants are similar in designs and sizes to OsseoSpeed™ Plus implants cleared in the primary predicate K120414. The subject device implants are provided in body diameters of 3.0 mm, 3.6 mm, 4.2 mm, and 5.4 mm. The subject device implants are provided in total lengths ranging from 8 mm to 16 mm. The primary predicate device implants are provided in body diameters of 3.0 mm, 3.6 mm, 4.2 mm, and 5.4 mm and total lengths ranging from 6 mm to 17 mm. The platform diameter for each size is the same as the (maximum) body diameter for both the subject device and the primary predicate device. Both the subject device and primary predicate device implants have an anti-rotational feature for the implant-abutment interface. Both the subject device and primary predicate device are provided sterile to the end-user.
Additionally, the subject device Kontact dental implants are manufactured from titanium alloy conforming to ASTM F136 and ISO 5832-3. Titanium alloy is commonly used to manufacture dental implants and prosthetic components. The endosseous threaded surface of the subject device is grit-blasted with non-resorbable aluminum oxide (Al2O3) particles to facilitate osseointegration. The reference device K200386 is in support of substantial equivalence for this technological characteristic
{10}------------------------------------------------
because the endosseous threaded surface of the reference device also is modified by blasting with Al2O3 particles. Therefore, the subject device implants are substantially equivalent to the primary predicate K120414 and reference device K200386 implants.
Subject Device Prosthetic Components
The subject device Cover Screw and Ball Abutment designs are substantially equivalent in material and dimensions to similar devices in the primary predicate K120414.
The subject device Healing Screw designs are substantially equivalent in material and dimensions to similar healing abutments in reference devices in K123988 and K170392.
The subject device Temporary Abutment designs are substantially equivalent in material and dimensions to similar abutments in the reference devices K163194 and K192347. Similarly, the subject device UniPost Abutment designs are substantially equivalent in material and dimensions to similar abutments in the reference devices K163194, and to the EZ Post and Solid Abutments in K152787. The prosthetic post height of the UniPost Abutments is substantially equivalent to the Low Profile Abutment, K092341.
The subject device Non-Scalloped Straight Abutment and Scalloped Straight Abutment designs are substantially equivalent in material and dimensions to similar abutments in the reference devices K170392 and K192347.
The subject device Non-Scalloped Abutment and Scalloped Angled Abutment designs are substantially equivalent in material and dimensions to similar abutments in the reference devices K123988, K182448, and K200992.
The subject device FitPost Abutments are substantially equivalent in intended use, material, and designs to the reference device Milling Abutment in K192347 and K182448, and to the Solid Abutments in K152787.
The subject device NanoPost Straight Abutments, NanoPost Angled Abutments, and Conical Abutments are substantially equivalent in material, design, and dimensions to similar abutments in the reference device K182448, and to the Low Profile Abutments, K092341.
The subject device IsoPost Abutments are substantially equivalent in material, design, and dimensions to the reference device K131644 and K153509, and to the Straumann TLX Novaloc Abutments in K203355.
Mechanical performance testing of the subject device was performed in conformance to ISO 14801. The reference device K183518 is to support substantial equivalence of the fatigue limit for subject device abutments compatible with the subject device 3.0 mm diameter implants. The fatigue limit data demonstrated that constructs of all other subject device abutments in combination with all other subject device implants have sufficient strength for their intended use.
{11}------------------------------------------------
CONCLUSION
The subject device, the primary predicate device, and the reference devices have the same intended use, have similar technological characteristics, and are materials. The subject device, the primary predicate, and reference devices encompass the same range of physical dimensions, are packaged in similar materials, and are to be sterilized using similar methods. The data included in this submission demonstrate substantial equivalence to the predicate devices listed above.
{12}------------------------------------------------
Comparison of Indications for Use Statements
| Subject Device | Indications for Use Statement | |
|---|---|---|
| Kontact Dental Implant SystemBiotech Dental, SAS | Kontact™ Dental Implant System is indicated for use in partially or fully edentulous patients to support maxillary or mandibular single unit, multiple-unit, or occlusalloading when good primary stability is achieved and the occlusal loading is appropriate. Kontact 3 mm diameter implants and prosthetics components are indicated formandibular incisor regions. | |
| Primary Predicate Device | ||
| K120414OsseoSpeed™ PlusAstra Tech AB | The Astra Tech Dental Implants are intended for both one- and two-stage surgical procedures in the following situations and with the following clinical protocols:replacing single and multiple missing teeth in the mandible and maxilla, immediate placement in extraction sites and in situations with a partially or completely healed alveolar ridge, especially indicated for use in soft bone applications where implants with other implant surface treatments may be less effective, immediate loading in all indications, except in single tooth situations on implants shorter than 8 mm, or in soft bone (type IV) where implant stability may be marginal. The intended use for OsseoSpeed™ Plus 3.0S is limited to replacement of maxillary lateral incisors and mandibular incisors. | |
| Abutments:Astra Tech Implant System Plus abutments are intended to be used in conjunction with Astra Tech Implant System Pius in fully edentulous or partially edentulousoverdentures. | ||
| Atlantis Abutments:The Atlantis™ Abutment is intended for use with an endosseous implant to support a prosthetic device in a partially or completely edentulous; patient. It is intended that theprosthesis can be cemented, screw retained or friction fit to the abutment. The abutment screw is intended to secure the abutment to the endosseous implant. | ||
| The Atlantis™ Crown Abutment in Zirconia is intended for use with an endosseous; implant to function as a substructure that also serves as the final restoration. Theabutment screw is intended to secure the crown abutment to the endosseous implant. | ||
| Reference Devices | ||
| K123988AnyOne™ Internal Implant SystemMegaGen Implant Co., Ltd | The AnyOne™ Internal Implant System is intended to be surgically placed in the maxillary or mandibular molar areas for the purpose providing prosthetic support forindividuals. It is used to restore a patient's chewing function. Smaller implants (less than Ø6.0 mm) are dedicated for immediate loading when good primary stability in themolar region and are indicated for delayed loading. | |
| K131644Ankylos SynCone® Abutment 5°Dentsply International, Incorporated | SynCone® Abutments on osseointegrate ImplantsAnchorage of dentures retained by taper friction and supported by ANKYLOS® implants. | |
| SynCone® Abutments for Immediate loadingImmediate loading of an implant supported prosthesis in an edentulous mandible supported by 4 ANKYLOS® implants of at least 11 mm in length and placed in the mandible. | ||
| K153509GPS® Angled AbutmentsImplant Direction Sybron Manufacturing LLC | GPS® Angled Abutments are designed to be used in support of a dental implant(s) to provide support for prosthetic restorations in a partially or completely edentulousoverdenture. Abutments are intended for use in the mandible or maxilla. Implants can be indicated for immediate loading when good primary stability has been achieved. | |
| Compatibility:Legacy System: Prosthetically compatible with Zimmer Dental Tapered Screw-Vent system 3.5mm platform implants (3.7mmD, 4.1mmD, 8mm-16mm Length, 4.5mmD, 5.0mmD)(6.0mmD, 8mm-16mm Length).SwishTapered System: Prosthetically compatible with Straumann Standard and Standard Plus system RN platform implants (3.3mmD-4.8mmD, 6mm-16mm Length).SwishActive Implants: SwishActive implants are prosthetically compatible with InterActive 3.0 and 3.4mm abutments and Nobel Biocare conical connection NobelActive™RP (Regular Platform - 3.4mm diameter) titanium abutments. InterActive 3.0 and 3.4mm abutments are prosthetically compatible with Nobel Biocare conical connection NobelActive™NobelActive™ RP (Regular Platform - 3.4mm diameter) (3.5-5.0mmD, 8.5- 18mmLength).InterActive System: InterActive implants are prosthetically compatible with InterActive 3.0 and 3.4mm abutments and Nobel Biocare conical connection NobelActive™Platform - 3.4mm diameter) titanium abutments. InterActive 3.0 and 3.4mm abutments are prosthetically compatible with Nobel Biocare conical connection NobelActive™Platform - 3.4mm diameter) (3.5-5.0mmD, 8.5- 18mmLength) implants. | ||
| K163194Neodent Implant System - GM LineJJGC Industria e Comercio de Materiais Dentarios SA | Indications for Use for GM implants and conventional abutments:The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices such as artificial teeth,for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. | |
| Indications for Use for GM Titanium Base abutments:Titanium Base Abutment is a titanium base placed onto Neodent dental implants to provide support for customized prosthetic restorations. It is used with a coping for cement-retainedrestorations, or screw-retained single restorations.All digitally designed copings and/or crowns for use with the Neodent Titanium Base Abutment System are intended to be sent to Straumann for manufacture and distribution. | ||
| Indications for Use for GM Pro Peek Abutments:The Pro PEEK Abutments are indicated to be used on Neodent implants to provide temporary support for prosthesis structure for up to 6 months. They can be used to enhancestability. | ||
| K170392S.I.N. Dental Implant SystemS.I.N. - Sistema de Implante Nacional S.A. | S.I.N. Dental Implant System is intended for placement in the maxillary or mandibular arch to provide support for single-unit or multi-unit restorations. When appropriate, it can beloaded when good primary stability is achieved and with appropriate occlusal loading. Implants with lengths less than 7 mm are intended for delayed loading only. | |
| Indications for Use Statement | ||
| K182448AnyRidge Octa 1 Implant SystemMegaGen Implant Co., Ltd | The AnyRidge Octa 1 Implant System is intended to be surgically placed in the maxillary or mandibular arches for the purpose of providing prosthetic support for dental restorations (Crown, bridge, and dentures) in fully and partially edentulousindividuals. It is used to restore a patient's chewing function in the following situations and with the clinical protocols:- Delayed loading.- Immediate loading when good primary stability is achieved and with appropriate occlusal loading.Larger implants are dedicated for the molar region. | |
| K192347ST Internal Implant SystemMegaGen Implant Co., Ltd | The ST Internal Implant System is intended to be surgically placed in the maxillary or mandibular molar areas for the purpose providing prosthetic support for dental restorations (Crown, bridge, and dentures) in fully and partially edentulousindividuals. It is used to restore a patient's chewing function. Smaller implants (less than 06.0mm) are dedicated for immediate loading when good primary stability is achieved and with appropriate occlusal loading. The implants placed in themolar region and are indicated for delayed loading. | |
| K200992S.I.N. Dental Implant SystemS.I.N. - Sistema de Implante Nacional S.A. | S.I.N. Dental Implant System is intended for placement in the maxillary or mandibular arch to provide support for single-unit or multi-unit restorations. When a one-stage approach is applied, implants can be immediatelyloaded when good primary stability is achieved and with appropriate occlusal loading. | |
| Reference Devices | ||
| K151328PURE Ceramic ImplantsStraumann USA | The Straumann® PURE Ceramic Implant (Monotype) is indicated for restoration in single tooth gaps and in an edentulous or partially edentulous jaw. The prosthetic restorations used are similar in size and shapeto the implants through the corresponding components.The Ø3.3 mm reduced diameter implants are recommended for central and lateral incisors only.The Straumann® PURE Ceramic Implant Protective Cap is intended to protect the Straumann® PURE Ceramic Implant (Monotype) during the healing phase after implant placement for up to 30 days.Temporary copings are intended to serve as a base for temporary crown or bridge restoration for the Straumann® PURE Ceramic Implant (Monotype) for up to 30 days. | |
| K181381A.B. Dental Devices® Dental Implants SystemA.B Dental Device Ltd | A.B. DENTAL DEVICES® Dental Implants System is indicated for use in surgical and restorative applications for placement in the bone of the upper or lower jaw to provide support for prosthetic restorations and to restore apatient's chewing function. A.B. DENTAL DEVICES® Dental Implants System is indicated also for immediate loading when good primary stability is achieved and with appropriate occlusal loading. | |
| K183518Preat Abutments,Preat Corporation | Preat Abutments are intended to be used in conjunction with endosseous dental implants in the maxillary or mandibular arch to provide support for single-unit or multi-unit prosthetic restorations. These are prefabricatedparts. Specifically, the titanium base and mesostructured components make up a two-piece abutment. All digitally designed custom abutments, superstructures, and/or hybrid crowns for use with Preat Abutments must bevalidated milling center for manufacture. | |
| Compatible Implant System | Implant Body Diameter (mm) / Implant Platform Diameter (mm) | |
| 3i OSSEOTITE® Certain® | 3.25 / 3.4 | |
| 4.0 / 4.1 | ||
| 5.0 / 5.0 | ||
| 6.0 / 6.0 | ||
| Astra Tech OsseoSpeed™ | 3.0 / 3.0 | |
| 3.5, 4.0 / 3.5/4.0 | ||
| 4.5, 5.0 / 4.5/5.0 | ||
| BioHorizons Tapered Internal | 3.0 / 3.0 | |
| 3.5 / 3.5 | ||
| 4.0 / 4.5 | ||
| HIOSSEN ET III | 3.5 / Mini | |
| Implant Direct Legacy | 4.0, 4.5, 5.0, 6.0, 7.0 / Regular | |
| 3.2 / 3.0 | ||
| 3.7, 4.2 / 3.5 | ||
| 4.7, 5.2 / 4.5 | ||
| 5.7, 7.0 / 5.7 | ||
| MegaGen AnyRidge | 3.5, 4.0, 4.5, 5.0, 5.5 / 3.5 | |
| Neoss | 3.5, 4.0, 4.5, 5.0, 5.5 / 4.1 | |
| NobelActive® | 3.5 / NP | |
| Nobel Replace™ | 4.3, 5.0 / RP | |
| 3.5 / NP | ||
| 4.0, 4.3, 5.0 / RP | ||
| 5.0 / WP | ||
| Straumann® Bone Level | 6.0 / 6.0 | |
| Straumann® Tissue Level | 3.3 / NC | |
| 4.1, 4.8 / RC | ||
| Zimmer Screw-Vent®/Tapered Screw-Vent® | 3.3, 4.1, 4.8 / RN | |
| 4.8, 6.5 / WN | ||
| 3.3, 3.7, 4.1 / 3.5 | ||
| 4.7 / 4.5 | ||
| 6.0 / 5.7 | ||
| K200386Z5-BLZ-Systems AG | Z5-BL implants are designed for surgical implantation into the upper and lower jaw for the attachment of prosthodontic appliances to replace missing teeth. Z5-BL implants are suitable for partially edentulous patients sufferingfrom them. Z5-BL implants are intended for delayed loading. | |
| K152787ST Internal Fixture SystemT-Plus Implant Tech. Co., Ltd. | The ST internal Fixture System is intended to be placed in the upper or lower jaw to support prosthetic devices, such as artificial teeth, and to restore a patient's chewing function. This may be a two-stage surgical procedureor a single stage surgical procedure.The ST Internal Fixture System is intended for use for immediate loading when good primary stability is achieved and with appropriate occlusal loading. | |
| K092341Low Profile AbutmentBiomet 3i, Inc. | BIOMET 3i Low Profile Abutments are intended for use as accessories to endosseous dental implants to support a prosthetic device.in a partially or completely edentulous patient. A dental prosthesis, including a single ormultiple tooth prosthesis, in the mandible or maxilla. The prosthesis is screw retained to the abutment. | |
| K203355Straumann TLX Novaloc and Cementable AbutmentsInstitut Straumann AG | TLX Novaloc AbutmentsThe Straumann® Retentive System is indicated for the attachment of full or partial dentures on Straumann dental implants (NT, RT, and WT).TLX Cementable AbutmentsProsthetic components directly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Final abutments may be placed into occlusion for implant function or for implants that are fully osseointegrated. |
denture dental restorations. Kontact Dental Implant System is indicated for immediate d for use in surgical and restorative applications in the maxillary lateral incisor or
nay be difficult to obtain and immediate loading may not be appropriate.
maxillary and/or mandibular arches to provide support for crowns, bridges or
ed for use to support single and multiple tooth prostheses, in the mandible or maxilla. The
n partially or completely edentulous; patients. The prosthesis is screw retained. The
t for dental restorations (Crown, bridges, and overdentures) in partially or fully edentulous ity is achieved and with appropriate occlusal loading. Larger implants are dedicated for the
rforaminally.
lous patient. These abutments are designed to only receive a fabricated multi-unit bridge or hieved and with appropriate occlusal loading.
4.5mm platform implants (4.7mmD, 8mm-16mm Length), and 5.7mm platform implants
gth)
elActive™ NP (Narrow Platform - 3.0mm diameter) and NobelActive™ nection NobelActive™ NP (Narrow Platform- 3.0mm diameter) and
ctive™ NP (Narrow Platform – 3.0mm diameter) and NobelActive™ RP (Regular el Active™ NP (Narrow Platform- 3.0mm diameter) and NobelActive™ RP (Regular
eth, to restore chewing function. It may be used with single-stage or two-stage procedures,
and crown, or crown alone, and is indicated for cement-retained single or multi-unit
validated milling center.
in one or two stage procedures and also immediate load when there is good primary
ne-stage approach is applied, the S.I.N Dental Implant System is intended for immediate
{13}------------------------------------------------
Comparison of Indications for Use Statements
bridges, and overdentures) in partially or fully edentulous
dges, and overdentures) in partially or fully edentulous priate occlusal loading. Larger implants are dedicated for the
l, the S.I.N Dental Implant System is intended for immediate
gle crowns, fixed partial or full dentures, which are connected
6 months.
thetic devices, such as artificial teeth, in order to restore the loading.
tions. The Titanium Base abutments consists of two major
with Titanium Base or Titanium Blank are to be sent to a Preat
tients with metal allergies and the chronic diseases resulting
accomplished using either a two stage surgical procedure
outment is intended for use to support single and
ts with sufficient primary stability and with appropriate
{14}------------------------------------------------
Comparison of Technological Characteristics, Implants
| Subject Device | Primary Predicate | Reference Device | |
|---|---|---|---|
| Feature | Kontact Dental Implant System | K120414 | K200386 |
| Biotech Dental, SAS | OsseoSpeed™ PlusAstra Tech AB | Z5-BLZ-Systems AG | |
| Product Code | DZE, NHA | DZE, NHA | DZE, NHA |
| Reason for Predicate/ Reference Device | n/a | Implant body/platform diameter, length, and how provided | Implant Endosseous Surface |
| Implant Designs | |||
| Prosthetic Interface Connection | Internal | Internal | Internal |
| Body/Platform Diameter, mm | 3.0, 3.6, 4.2, 4.8, 5.4 | 3.0, 3.6, 4.2, 4.8. 5.4 | 3.6 |
| Lengths, mm | 8, 10, 12, 14, 16 | 6, 8, 9, 11, 13, 15, 17 | 8, 10, 12 |
| Implant Material | Titanium alloy(ASTM F136 and ISO 5832-3) | Commercially pure titanium(ASTM F67) | Y-TZP zirconia conforming to ISO 13356 |
| Implant Endosseous Surface | Aluminum Oxide (Al2O3) Blasted | OsseoSpeed, TiO2-blasted fluoride-modified | Aluminum Oxide (Al2O3) Blasted |
| How Provided | |||
| Sterility | Sterile | Sterile | Sterile |
| Sterilization Method | Gamma Sterilization | Not publicly available | Plasma Gas |
| Usage | Single patient, single-use | Single patient, single-use | Single patient, single-use |
{15}------------------------------------------------
Comparison of Technological Characteristics, Prosthetic Components
| Subject Device | Primary PredicateDevice | K123988 | K170392 | K163194 | K192347 | K182448 | K200992 | K131644 | K131664 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feature | Kontact Dental Implant System | OsseoSpeed™ Plus | AnyRidge Octa 1 ImplantSystem | S.I.N. Dental ImplantSystem | Neodent Implant System -GM Line | ST Internal ImplantSystem | AnyRidge Octa 1 ImplantSystem | S.I.N. Dental ImplantSystem | Ankylos SynCone®Abutment 5° | GPS® |
| Biotech Dental, SAS | Astra Tech AB | MegaGen Implant Co., Ltd | S.I.N. - Sistema deImplante Nacional S.A. | JJGC Industria eComercio de MateriaisDentarios SA | MegaGen Implant Co.,Ltd | MegaGen Implant Co.,Ltd | S.I.N. - Sistema deImplante Nacional S.A. | Dentsply International,Incorporated | ImplantManufacturer | |
| Product Code | DZE, NHA | DZE, NHA | DZE, NHA | DZE, NHA | DZE, NHA | DZE, NHA | DZE, NHA | DZE, NHA | NHA | |
| Reason for Predicate/Reference Device | n/a | Cover ScrewBall Abutmentsdesign and dimensions | Healing ScrewsTemporary Abutmentsdesign and dimensions | Healing ScrewsStraight Abutmentsdesign and dimensions | Temporary AbutmentsUniPost Abutmentsdesign and dimensions | Temporary AbutmentsStraight AbutmentsFitPost Abutmentdesign and dimensions | Conical AbutmentsNanoPost AbutmentsFitPost AbutmentAngled Abutmentsdesigns and dimensions | Angled Abutmentsdesigns and dimensions | IsoPost Abutmentsdesigns and dimensions | IsoPost Abutmentsdesigns |
| Abutment Designs | ||||||||||
| Cover Screws | Coronal Ø: 2.5 mm, 2.9 mmNon-IndexedTitanium Alloy (ASTM F136),anodized and non-anodized | Coronal Ø: 2.5-4.6 mmNon-IndexedTitanium Alloy, anodized | ||||||||
| Healing Screws | Coronal: Ø 4.1-7.1 mmGingival Height: 1-5 mmNon-IndexedTitanium Alloy (ASTM F136)anodized and non-anodized | Healing AbutmentCoronal Ø 4.2-9.7 mmGingival Height: 2.3-6.8 mmNon-IndexedTi-6A1-4V ELI | Healing Abutment UnititeCoronal: Ø 3.3, 4.5 mmGingival Height 0.8-5.5 mmNon-IndexedTitanium Alloy (ASTM F136) | |||||||
| Temporary Abutments | Prosthetic Platform Ø: 4.0 mm, 4.5 mmGingival Height: 1-5 mmIndexedTitanium Alloy (ASTM F136)Knurled | GM Exact AbutmentsProsthetic Platform Ø: 3.5 mm,4.8 mmGH: 0.8-5.5 mmNon-IndexedTi-6A1-4V ELI (ASTM F136) | Temporary AbutmentProsthetic Platform Ø:4.0 mm,4.5 mmGingival Height: 1.0 mm,3.0 mmIndexed & Non-IndexedTi-6A1-4V ELIGrooved | |||||||
| Straight Abutments | Prosthetic Platform Ø: 3.7-6.6 mmGingival Height: 1-5 mmAngle: 0°Indexed and Non-IndexedTitanium Alloy (ASTM F136),anodized and non-anodized | Abutment Cemented SITUnititeProsthetic platform Ø 3.3 mm,4.5 mmGingival height: 0.8-5.5 mmAngle 0°Non-indexedTitanium Alloy (ASTM F136) | Solid AbutmentProsthetic Platform Ø: 4-7 mmGingival Height: 1-5.0 mmAngle: 0°IndexedTi-6A1-4V ELI, anodized | |||||||
| Angled Abutments | Prosthetic Platform Ø: 3.7- 6.6 mmGingival Height: 1-5 mmAngle: 7.5°, 15°, 22°Indexed, Non-IndexedTitanium Alloy (ASTM F136),anodized, non-anodized | Angled AbutmentProsthetic Platform Ø: 4.5 mm.5.5 mmGingival Height: 2.5 mm, 4.5mmAngle: 15°, 25°Indexed and Non-IndexedTi-6A1-4V ELI, anodized | Angled AbutmentProsthetic Platform Ø: 4-7 mmGingival Height: 1-5 mmAngle: 15°, 25°Indexed & Non-IndexedTi-6A1-4V ELI,anodized, non-anodized | Abutment Angled MorseProsthetic Platform Ø: 3.5,4.5 mmGingival Height: 1-5 mmAngle: 17°IndexedTitanium Alloy (ASTM F136) | ||||||
| FitPost Abutment | Prosthetic Platform Ø: 5.1 mm, 6.6 mmGingival Height: 1-5 mmAngle: 0°IndexedTitanium Alloy (ASTM F136) | Milling AbutmentProsthetic Platform Ø: 4-7 mmGingival Height: 1.5 mm,3.0 mmAngle: 0°IndexedTi-6A1-4V ELI, anodized | Milling AbutmentProsthetic Platform Ø: 6.0 mm,8.0 mmGingival Height: 1-5 mmAngle: 0°Indexed & Non-IndexedTi-6A1-4V ELI, anodized | |||||||
| NanoPost Straight Abutments | Prosthetic Platform Ø: 4.3 mm, 5.5 mmGingival Height: 1-5 mmAngle: 0°Indexed, Non-IndexedTitanium Alloy (ASTM F136), anodized | EZ Post AbutmentProsthetic Platform Ø: 4-7 mmGingival Height: 1-5 mmAngle: 0°,Indexed, Non-IndexedTi-6A1-4V ELI, anodized | ||||||||
| NanoPost Angled Abutments | Prosthetic Platform Ø: 4.3 mmGingival Height: 1-5 mmAngle: 7.5°, 15°IndexedTitanium Alloy (ASTM F136), anodized | Angled AbutmentProsthetic Platform Ø: 4-7 mmGingival Height: 1-5 mmAngle: 15°, 25°Indexed & Non-IndexedTi-6A1-4V ELI, anodized,non-anodized | ||||||||
| UniPost Abutments | Prosthetic Platform Ø: 4.3 mmGingival Height: 1-5 mmThreadedTitanium Alloy (ASTM F136), anodized |
Г
| K153509 |
|---|
| S® Angled Abutment |
| Implant Direct SybronManufacturing, LLC |
| NHA |
| ost Abutmentsgns and dimensions |
| Solid AbutmentsØ: 5.0-6.0 mmGingival Height: 1 mm |
| EZ Post AbutmentsØ: 5.0-7.0 mmGingival Height: 1-5 mmSolid AbutmentsØ: 5.0-7.0 mmGingival Height: 1-5 mm |
| K152787 |
|---|
| ST Internal FixtureSystem |
| T-Plus Implant Tech. Co.,Ltd. |
| DZE< NHA |
| K092341 |
|---|
| Low Profile Abutment |
| Biomet 3i, Inc. |
| NHA |
| Low Profile AbutmentsProsthetic Post Height: 2.2 mm |
| K203355 |
|---|
| Straumann TLX Novalocand CementableAbutments |
| Institut Straumann AG |
| NHA |
{16}------------------------------------------------
510(k) Summary
Page 14 of 14
| Subject Device | Primary PredicateDevice | Reference Devices | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K120414 | K123988 | K170392 | K163194 | K192347 | K182448 | K200992 | K131644 | K153509 | K152787 | K092341 | K203355 | ||
| Feature | Kontact Dental Implant System | OsseoSpeed™ Plus | AnyRidge Octa 1 ImplantSystem | S.I.N. Dental ImplantSystem | Neodent Implant System -GM Line | ST Internal ImplantSystem | AnyRidge Octa 1 ImplantSystem | S.I.N. Dental ImplantSystem | Ankylos SynCone®Abutment 5° | GPS® Angled Abutment | ST Internal FixtureSystem | Low Profile Abutment | Straumann TLX Novalocand CementableAbutments |
| Biotech Dental, SAS | Astra Tech AB | MegaGen Implant Co.,Ltd | S.I.N. - Sistema deImplante Nacional S.A. | JJGC Industria eComercio de MateriaisDentarios SA | MegaGen Implant Co.,Ltd | MegaGen Implant Co.,Ltd | S.I.N. - Sistema deImplante Nacional S.A. | Dentsply International,Incorporated | Implant Direct SybronManufacturing, LLC | T-Plus Implant Tech. Co.,Ltd. | Biomet 3i, Inc. | Institut Straumann AG | |
| Conical Abutments | Prosthetic Platform Ø: 4.0 mm, 4.9mmGingival Height: 1-5 mmAngle: 0°, 17°Indexed, Non-IndexedTitanium Alloy (ASTM F136), anodized | Prosthetic Platform Ø: 4-5 mmGingival Height: 1-5 mmAngle: 0°, 17°, 30°Indexed, Non-IndexedTi-6A1-4V ELI, anodized,non-anodized | Low Profile AbutmentsAngle: 0°Gingival Height: 1-5 mmAngle: 17°Gingival Height: 1-4 mm | ||||||||||
| IsoPost Abutments | Overdenture TypeGingival Height: 1.5-5 mmAngle: 0°, 7.5°, 15°, 22°Non-IndexedTitanium Alloy (ASTM F136), anodized | Overdenture TypeGH: 1.5-4.5 mmAngle: 0°, 7.5°, 15°, 22.5°, 30°IndexedTitanium Alloy (ASTM F136) | Overdenture TypeGingival Height: 1.5-5 mmAngle: 0°IndexedTi-6Al-4V ELI, TiN coated | Novaloc AbutmentsAngle: 0°Gingival Height: 1-6 mmAngle 15°Gingival Height: 2-6 mm | |||||||||
| Ball Abutments | Overdenture TypeGingival Height: 1-5 mmBall Ø: 2.25 mmNon-IndexedTitanium Alloy (ASTM F136) | Ball AbutmentsGingival Height: 1-7 mmBall Ø 2.25 mmNon-IndexedTitanium (ASTM F67) | |||||||||||
| How Provided | |||||||||||||
| Sterility | Non-Sterile; Sterile (Cover Screws) | Sterilize | Non-Sterile | Sterilize | Sterile | Non-Sterile | Non-Sterile | Sterilize | Non-Sterile | Non-Sterile | |||
| Sterilization Method | Moist Heat; Gamma Irradiation | Gamma Irradiation | Moist Heat | Gamma Irradiation | Ethylene Oxide Exposure | Moist Heat | Moist Heat | Gamma Irradiation | Moist Heat | Moist Heat | |||
| Usage | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use | Single patient, single-use |
Kontact™ Dental Implant Systems
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.